Gordon Moran
University of Nottingham · The university of Nottingham, Faculty of Medicine & Health Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gordon Moran as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:11 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06956703 · NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort StudyUniversity of Nottingham · recruiting · Gastro-Intestinal Disorder, Crohn Disease, Ulcerative Colitis · principal investigator
- N/ANCT05572008 · ProteIn Nutrition in Crohn's DiseaseUniversity of Nottingham · unknown · Crohn Disease · principal investigator
- N/ANCT03325582 · MR Assessment of Perianal Crohn's DiseaseUniversity of Nottingham · unknown · Perianal Fistula · principal investigator
- Ph4NCT03261206 · Stopping Aminosalicylate Therapy in Inactive Crohn's DiseaseAlimentiv Inc. · completed · Crohn Disease, Remission · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:11 UTC. The ranking covers the 200 most relevant of 35 PubMed records, and a shared surname and initials can bring in a namesake. All 35 on PubMed
- A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis.N Engl J Med · 2020452 citationsRCR 34.3
- 317 citationsRCR 10.0
- A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.Lancet Gastroenterol Hepatol · 2024288 citationsRCR 53.7
- Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.Lancet Infect Dis · 2014264 citationsRCR 10.9
- Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess.N Engl J Med · 2016169 citationsRCR 8.4
- Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.J Clin Invest · 2020111 citationsRCR 6.7
- A randomized trial of coenzyme Q10 in mitochondrial disorders.Muscle Nerve · 2010110 citationsRCR 3.1
- Antibiotics-First Versus Surgery for Appendicitis: A US Pilot Randomized Controlled Trial Allowing Outpatient Antibiotic Management.Ann Emerg Med · 201782 citationsRCR 4.9
- 70 citationsRCR 4.7
- 66 citationsRCR 2.0